1. Home
  2. INDP vs ALLT Comparison

INDP vs ALLT Comparison

Compare INDP & ALLT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Indaptus Therapeutics Inc.

INDP

Indaptus Therapeutics Inc.

N/A

Current Price

$3.18

Market Cap

438.4M

Sector

Health Care

ML Signal

N/A

Logo Allot Ltd.

ALLT

Allot Ltd.

N/A

Current Price

$7.85

Market Cap

440.8M

ML Signal

N/A

Company Overview

Basic Information
Metric
INDP
ALLT
Founded
2000
1996
Country
United States
Israel
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Telecommunications Equipment
Sector
Health Care
Telecommunications
Exchange
Nasdaq
Nasdaq
Market Cap
438.4M
440.8M
IPO Year
2021
2006

Fundamental Metrics

Financial Performance
Metric
INDP
ALLT
Price
$3.18
$7.85
Analyst Decision
Strong Buy
Analyst Count
0
6
Target Price
N/A
★ $12.64
AVG Volume (30 Days)
211.2K
★ 396.8K
Earning Date
11-13-2026
11-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ N/A
EPS
N/A
★ N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$14.77
Revenue Next Year
N/A
$10.96
P/E Ratio
★ N/A
$469.21
Revenue Growth
N/A
N/A
52 Week Low
$0.92
$6.12
52 Week High
$5.96
$11.92

Technical Indicators

Market Signals
Indicator
INDP
ALLT
Relative Strength Index (RSI) 50.79 40.34
Support Level $2.17 $7.19
Resistance Level $3.71 $7.95
Average True Range (ATR) 0.34 0.41
MACD -0.02 -0.10
Stochastic Oscillator 51.34 20.54

Price Performance

Historical Comparison
INDP
ALLT

About INDP Indaptus Therapeutics Inc.

Indaptus Therapeutics Inc is a clinical biotechnology company that has developed a novel and patented systemically-administered anti-cancer and anti-viral immunotherapy. Its approach is based on the hypothesis that efficient activation of both innate and adaptive immune cells and associated anti-tumor and anti-viral immune responses will require a multi-targeted package of immune system activating signals that can be administered safely intravenously. Its patented technology is composed of single strains of attenuated and killed, non-pathogenic, Gram-negative bacteria, designed to have reduced i.v. toxicity, but largely uncompromised ability to prime or activate many of the cellular components of innate and adaptive immunity. Its candidate, Decoy20 is for patients with solid tumors.

About ALLT Allot Ltd.

Allot Ltd is a provider of security and network intelligence solutions for mobile, fixed, and cloud service providers, as well as enterprises. It offers network-based security solutions such as mobile security, DDoS protection, and IoT security, along with network analytics and traffic management. It focuses on expanding its Security-as-a-Service (SECaaS) offerings through the Allot Secure product family, which delivers unified protection for consumers and SMBs across mobile, fixed, and 5G networks. Its Allot Smart solutions enable service providers to analyze and manage network data, optimize performance, reduce costs, and enhance user experience. It has a customer base in Europe, which generates maximum revenue, as well as in Asia and Oceania, the Americas, the Middle East, and Africa.

Share on Social Networks: